TECENTRIQ Drug Use Surveillance(advanced or recurrent non-small cell lung cancer)
Not Applicable
- Conditions
- non-small cell lung cancer
- Registration Number
- JPRN-UMIN000031978
- Lead Sponsor
- Chugai Pharmaceutical Co. Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 1000
Inclusion Criteria
Not provided
Exclusion Criteria
No criteria
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The incidence of ADRs.
- Secondary Outcome Measures
Name Time Method - The time of onset of ADRs. - The treatment status and outcome of ADRs. - The incidence of ADRs for each patient baseline characteristic.